**‘No Biological Law Says We Must Age’: Sinclair Debuts Evolve Lecture Series at UNIC Athens**
The University of Nicosia (UNIC) Athens has officially launched its Evolve Lecture Series, featuring a prominent inaugural lecture by David Sinclair, a Harvard Medical School professor and leading researcher in the field of ageing. The event took place on June 4, 2026, at the Andreas Vesalius Amphitheatre on the UNIC Athens campus in Elliniko, drawing a full audience eager to hear Sinclair's insights on age reversal.
In his lecture titled “David Sinclair on Age Reversal: From Discovery to Human Trials,” Sinclair presented his groundbreaking ideas on ageing, challenging the conventional understanding of it as an inevitable process. He argued that ageing is not merely a natural progression but the underlying cause of many significant diseases, including cancer, heart disease, and Alzheimer’s. Sinclair emphasized that addressing ageing itself could yield far greater benefits for humanity than merely treating individual diseases.
Sinclair's perspective is rooted in his Information Theory of Ageing, which posits that the primary reason for ageing is the loss of epigenetic instructions within cells, rather than damage to the DNA itself. He described these epigenetic instructions as the "software" that guides cellular behavior. Over his three-decade career, Sinclair has made significant discoveries, including his early work on sirtuins and the role of NAD+ in cellular health.
A key focus of Sinclair's talk was the progress made in epigenetic reprogramming, which has shown promising results in laboratory settings. By utilizing three of the four “Yamanaka factors,” his research team has successfully reset the age of cells, regrown damaged optic nerves, and restored sight in animal models, including mice and monkeys. Sinclair noted that this innovative approach has now progressed to human trials, initiated through his company, Life Biosciences. The trials are currently focused on urgent eye conditions, such as glaucoma and NAION (non-arteritic anterior ischemic optic neuropathy), with the first patient already treated.
Sinclair also highlighted the role of artificial intelligence in accelerating research in this field. He explained how AI has enabled his laboratory to condense what would traditionally require over a century of experimentation into just a month, allowing for the rapid screening of billions of potential therapeutic molecules.
While Sinclair's ambitions are significant, he clarified that his goal is not to pursue immortality but rather to extend healthy years of life. He stated, “There is no law of biology that says we have to age,” reinforcing his belief that with the right scientific advancements, the process of ageing can be altered.
The lecture concluded with an engaging discussion among audience members, covering various topics related to ageing research, including funding challenges and the potential for regenerative medicine to replace damaged organs and joints rather than merely transplanting them.
The Evolve Lecture Series aims to bring together leading scientists, researchers, and innovators to explore the cutting-edge intersections of artificial intelligence, robotics, biotechnology, and human health. The series takes its name from UNIC's flagship research initiative, Evolve, which seeks to integrate nutrition, environment, human biology, and real-world data to develop new models for preventive and personalized medicine.
In recognition of his substantial contributions to the field of ageing research and the science of longevity, the University of Nicosia conferred upon Professor David Sinclair the title of Honorary Doctor (Doctor of Philosophy Honoris Causa) on June 5, 2026. This honor reflects the university's commitment to advancing knowledge and innovation in health and medicine.
As the Evolve Lecture Series continues, it promises to foster important discussions and developments in the future of health, potentially reshaping our understanding of ageing and longevity.